Literature DB >> 28569393

Multidimensional latent trait linear mixed model: an application in clinical studies with multivariate longitudinal outcomes.

Jue Wang1, Sheng Luo1.   

Abstract

Multilevel item response theory (MLIRT) models have been widely used to analyze the multivariate longitudinal data of mixed types (e.g., categorical and continuous) in clinical studies. The MLIRT models often have unidimensional assumption, that is, the multiple outcomes are clinical manifestations of a univariate latent variable. However, the unidimensional assumption may be unrealistic because some diseases may be heterogeneous and characterized by multiple impaired domains with variable clinical symptoms and disease progressions. We relax this assumption and propose a multidimensional latent trait linear mixed model (MLTLMM) to allow multiple latent variables and within-item multidimensionality (one outcome can be a manifestation of more than one latent variable). We conduct extensive simulation studies to assess the unidimensional MLIRT model and the proposed MLTLMM model. The simulation studies suggest that the MLTLMM model outperforms unidimensional model when the multivariate longitudinal outcomes are manifested by multiple latent variables. The proposed model is applied to two motivating studies of amyotrophic lateral sclerosis: a clinical trial of ceftriaxone and the Pooled Resource Open-Access ALS Clinical Trials database.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MCMC; clinical trial; item response theory; latent variable model; random effects

Mesh:

Substances:

Year:  2017        PMID: 28569393      PMCID: PMC5540878          DOI: 10.1002/sim.7347

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  21 in total

1.  Assessing individual quality of life in amyotrophic lateral sclerosis.

Authors:  S Clarke; A Hickey; C O'Boyle; O Hardiman
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Analysis of multivariate mixed longitudinal data: a flexible latent process approach.

Authors:  Cécile Proust-Lima; Hélène Amieva; Hélène Jacqmin-Gadda
Journal:  Br J Math Stat Psychol       Date:  2012-10-22       Impact factor: 3.380

3.  Joint Modeling of Ability and Differential Speed Using Responses and Response Times.

Authors:  Jean-Paul Fox; Sukaesi Marianti
Journal:  Multivariate Behav Res       Date:  2016-06-07       Impact factor: 5.923

4.  The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.

Authors:  Daniele Lo Coco; Santino Marchese; Vincenzo La Bella; Tommaso Piccoli; Albino Lo Coco
Journal:  Chest       Date:  2007-05-02       Impact factor: 9.410

5.  Analysis of longitudinal randomized clinical trials using item response models.

Authors:  Cees A W Glas; Hanneke Geerlings; Mart A F J van de Laar; Erik Taal
Journal:  Contemp Clin Trials       Date:  2008-12-24       Impact factor: 2.226

6.  Compensatory and non-compensatory multidimensional randomized item response models.

Authors:  Jean-Paul Fox; Rinke Klein Entink; Marianna Avetisyan
Journal:  Br J Math Stat Psychol       Date:  2013-05-28       Impact factor: 3.380

7.  Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis.

Authors:  Franco Franchignoni; Gabriele Mora; Andrea Giordano; Paolo Volanti; Adriano Chiò
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-20       Impact factor: 10.154

8.  How common are ALS plateaus and reversals?

Authors:  Richard S Bedlack; Timothy Vaughan; Paul Wicks; Jamie Heywood; Ervin Sinani; Roger Selsov; Eric A Macklin; David Schoenfeld; Merit Cudkowicz; Alex Sherman
Journal:  Neurology       Date:  2015-12-09       Impact factor: 9.910

9.  Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.

Authors:  James D Berry; Jeremy M Shefner; Robin Conwit; David Schoenfeld; Myles Keroack; Donna Felsenstein; Lisa Krivickas; William S David; Francine Vriesendorp; Alan Pestronk; James B Caress; Jonathan Katz; Ericka Simpson; Jeffrey Rosenfeld; Robert Pascuzzi; Jonathan Glass; Kourosh Rezania; Jeffrey D Rothstein; David J Greenblatt; Merit E Cudkowicz
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

10.  Why item response theory should be used for longitudinal questionnaire data analysis in medical research.

Authors:  Rosalie Gorter; Jean-Paul Fox; Jos W R Twisk
Journal:  BMC Med Res Methodol       Date:  2015-07-30       Impact factor: 4.615

View more
  5 in total

1.  A Bayesian approach for individual-level drug benefit-risk assessment.

Authors:  Kan Li; Sheng Luo; Sammy Yuan; Shahrul Mt-Isa
Journal:  Stat Med       Date:  2019-04-15       Impact factor: 2.373

2.  Application of longitudinal item response theory models to modeling Parkinson's disease progression.

Authors:  Haotian Zou; Varun Aggarwal; Glenn T Stebbins; Martijn L T M Müller; Jesse M Cedarbaum; Anne Pedata; Diane Stephenson; Tanya Simuni; Sheng Luo
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-08-09

3.  Joint modeling of multiple repeated measures and survival data using multidimensional latent trait linear mixed model.

Authors:  Jue Wang; Sheng Luo
Journal:  Stat Methods Med Res       Date:  2018-10-11       Impact factor: 3.021

4.  Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models.

Authors:  Sheng Luo; Haotian Zou; Christopher G Goetz; Dongrak Choi; David Oakes; Tanya Simuni; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2021-08-03

5.  Longitudinal association between an overall diet quality index and latent profiles of cardiovascular risk factors: results from a population based 13-year follow up cohort study.

Authors:  Fatemeh Nouri; Masoumeh Sadeghi; Noushin Mohammadifard; Hamidreza Roohafza; Awat Feizi; Nizal Sarrafzadegan
Journal:  Nutr Metab (Lond)       Date:  2021-03-10       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.